The final, formatted version of the article will be published soon.
REVIEW article
Front. Immunol.
Sec. Primary Immunodeficiencies
Volume 16 - 2025 |
doi: 10.3389/fimmu.2025.1519955
Multidisciplinary Approach to Treating Complex Immune Dysregulation Disorders: An Adaptive Model for Institutional Implementation
Provisionally accepted- 1 Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
- 2 Nationwide Children's Hospital, Columbus, Ohio, United States
- 3 Division of Allergy and Immunology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital, Chicago, Illinois, United States
- 4 Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
- 5 Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- 6 Cook Children's Medical Center, Fort Worth, Texas, United States
- 7 Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, Colorado, United States
- 8 School of Medicine, Emory University, Atlanta, Georgia, United States
- 9 Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- 10 Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States
- 11 Division of Pediatric Rheumatology, Department of Pediatrics, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States
- 12 Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, United States
- 13 Departments of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States
- 14 Division of Developmental Medicine, Boston Children's Hospital, Boston, Massachusetts, United States
- 15 Benioff Children's Hospital, University of California, San Francisco, San Francisco, California, United States
- 16 College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, Texas, United States
- 17 Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, Ohio, United States
- 18 Division of Pediatric Immunology, Allergy and Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, Ohio, United States
- 19 Center for Immunobiology, Texas Children's Hospital, Houston, Texas, United States
- 20 Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- 21 Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio, United States
- 22 Division of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States
- 23 Texas Children's Hospital, Houston, Texas, United States
- 24 Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States
- 25 C. S. Mott Children's Hospital, Ann Arbor, Michigan, United States
- 26 Division of Pediatric Hematology-Oncology, Department of Pediatrics, School of Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, United States
- 27 Department of Pediatrics, School of Medicine, University of California San Francisco, San Francisco, California, United States
- 28 Children's Hospital of Philadelphia, Philadelphia, United States
Patients with immune dysregulation may present with varying combinations of autoimmunity, autoinflammation, immunodeficiency, atopy, lymphoproliferation, and/or malignancy, often with multisystem involvement. Recognizing specific patterns of immune dysregulation, coordinating and interpreting complex diagnostic testing, and choosing initial (often empiric) treatment can be challenging. Centers are increasingly assembling multidisciplinary teams (MDTs) to standardize evaluation and optimize treatment of patients with complex immune dysregulation (immune dysregulation MDTs [immMDTs]). However, published information on the composition and function of immMDTs is sparse, and there is little guidance for those seeking to establish or optimize an immMDT. To inform this review, we assembled a panel of 24 pediatric providers from multiple specialties who actively participate in immMDTs to provide expert opinion. We also conducted a search of the available information on pediatric immMDTs from PubMed. Based on these insights, we summarize the structure and function of active immMDTs across the United States and focus on best practices and context-dependent solutions that may enable institutions with varying goals, patient populations, and resources to establish an immMDT.
Keywords: Multidisciplinary teams, Collaborative management, Immune dysregulation, Institutional implementation, Quality improvement research, Hemophagocytic lymphohistiocytosis Frontiers in Immunology 5238069 (maximum: 12, 000)
Received: 31 Oct 2024; Accepted: 10 Jan 2025.
Copyright: © 2025 Henderson, Abraham, Ahmed, Swigart, Canna, Chaimowitz, Chandrakasan, Coates, Connelly, Cooper, Duncan, French, Hazen, Hermiston, Nolan, Ray, Rose, Forbes, Schulert, Tejtel, Vogel, Walkovich, Zinter and Behrens. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Edward Behrens, Children's Hospital of Philadelphia, Philadelphia, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.